Cheng-Chin Chiang - Publications

Affiliations: 
2017-2019 Biomedical Engineering National Tsing Hua University, Hsinchu City, Taiwan, ROC 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Hsieh HT, Huang HC, Chung CW, Chiang CC, Hsia T, Wu HF, Huang RL, Chiang CS, Wang J, Lu TT, Chen Y. CXCR4-targeted nitric oxide nanoparticles deliver PD-L1 siRNA for immunotherapy against glioblastoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. 352: 920-930. PMID 36334859 DOI: 10.1016/j.jconrel.2022.10.047  0.777
2020 Huang KW, Hsu FF, Qiu JT, Chern GJ, Lee YA, Chang CC, Huang YT, Sung YC, Chiang CC, Huang RL, Lin CC, Dinh TK, Huang HC, Shih YC, Alson D, et al. Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Science Advances. 6: eaax5032. PMID 31998834 DOI: 10.1126/Sciadv.Aax5032  0.322
2019 Lin CH, Wen HC, Chiang CC, Huang JS, Chen Y, Wang SK. Polyproline Tri-Helix Macrocycles as Nanosized Scaffolds to Control Ligand Patterns for Selective Protein Oligomer Interactions. Small (Weinheim An Der Bergstrasse, Germany). e1900561. PMID 30977296 DOI: 10.1002/Smll.201900561  0.431
2018 Huang KW, Lai YT, Chern GJ, Huang SF, Tsai CL, Sung YC, Chiang CC, Hwang PB, Ho TL, Huang RL, Shiue TY, Chen Y, Wang SK. Galactose Derivative-Modified Nanoparticles for Efficient siRNA Delivery to Hepatocellular Carcinoma. Biomacromolecules. PMID 29808997 DOI: 10.1021/Acs.Biomac.8B00358  0.621
Show low-probability matches.